Medlab Clinical Ltd (ASX:MDC) Share Price

Company Profile

Business description
Medlab Clinical Ltd is an Australian biotechnology company that specializes in the application of NanoCelle drug delivery technology to existing and new pharmaceuticals to empower patients with chronic diseases and mental health conditions and enhance their lives.. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B, and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.
Contact
50 Kings Park Road
Level 2
West PerthWA6005
AUS
T: +61 281880311
https://www.medlab.co
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees

Recommended

Current operating conditions are challenging but over the long-term prospects are better.

Johannes Faul | 25 February 2025

Investors must weigh exciting growth stories against competitive dynamics and the price they are being asked to pay.

Joseph Taylor | 25 February 2025

Watching the data centre business and the debate around it, here’s what we think of Nvidia stock.

Morningstar | 25 February 2025

Index	Last price	Change	% Change
All Ordinaries	8,477.30	20.70	-0.24%
CAC 40	8,137.26	86.19	1.07%
DAX 40	22,732.24	321.97	1.44%
Dow JONES (US)	43,758.96	137.80	0.32%
FTSE 100	8,722.03	53.36	0.62%
HKSE	23,787.93	753.91	3.27%
NASDAQ	19,196.80	170.41	0.90%
Nikkei 225	38,142.37	95.42	-0.25%
NZX 50 Index	12,452.46	145.19	1.18%
S&P 500	5,991.45	36.20	0.61%
S&P/ASX 200	8,240.70	11.20	-0.14%
SSE Composite Index	3,380.21	34.17	1.02%